About TALZENNA® (talazoparib) TALZENNA is an oral inhibitor of poly ADP-ribose polymerase (PARP), which plays a role in DNA damage repair. Preclinical studies have demonstrated that TALZENNA blocks ...
The approval makes the PARP inhibitor available earlier in the line of treatment for some patients with metastatic disease.
Prostate cancer upgrading was independently associated with elevated PSA density and perineural invasion in a retrospective ...
A systematic review of 88 studies covering 29,256 people with prostate cancer maps preferences for digital supportive care, ...
A registered nutritionist can help patients plan meals that meet osteoporosis calcium needs without raising stone risk.
Calcium supplements clearly increase the risk of kidney and bladder stones in people who make calcium oxalate stones.
Considering Protaflo for your daily prostate support routine? Explore the brand-stated probiotic and botanical formula, package pricing, and advertised 90-day guarantee terms to help decide whether it ...
Brian Mazzarella, MD, discusses the landscape for intermediate-risk prostate cancer and early VAPOR 2 findings on water vapor ablation. In this video, Brian Mazzarella, MD, FACS, discusses the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results